NCT01939496: Evaluation of Blood Pressure Reduction, Safety, and Tolerability of Canagliflozin in Patients With Hypertension and Type 2 Diabetes Mellitus on Stable Doses of Anti-hyperglycemic and Anti-hypertensive Agents |
|
|
| Completed | 4 | 171 | US | Canagliflozin, Placebo | Janssen Scientific Affairs, LLC | Diabetes Mellitus, Type 2, Hypertension | 04/15 | 04/15 | | |
